B of A Securities Downgrades Oscar Health to Neutral, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has downgraded Oscar Health (NYSE:OSCR) from Buy to Neutral and lowered its price target from $25 to $21.
May 30, 2024 | 10:29 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities has downgraded Oscar Health from Buy to Neutral and reduced the price target from $25 to $21.
The downgrade from Buy to Neutral and the reduction in the price target from $25 to $21 by B of A Securities is likely to negatively impact investor sentiment and the stock price of Oscar Health in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100